Histopathology data for Slc30a4

Severity Score:
  • 0 = Normal
  • 1 = Mild (observation barely perceptible and not believed to have clinical significance)
  • 2 = Moderate (observation visible but involves minor proportion of tissue and clinical consequences of observation are most likely subclinical)
  • 3 = Marked (observation clearly visible involves a significant proportion of tissue and is likely to have some clinical manifestations generally expected to be minor)
  • 4 = Severe (observation clearly visible involves a major proportion of tissue and clinical manifestations are likely associated with significant tissue dysfunction or damage)
Significance Score:
  • 0 = Not significant: Interpreted by the histopathologist to be a finding attributable to background strain (e.g. low-incidence hydrocephalus, microphthalmia) or incidental to mutant phenotype (e.g. hair-induced glossitis, focal hyperplasia, mild mononuclear cell infiltrate).
  • 1 = Significant: Interpreted by the histopathologist as a finding not attributable to background strain and not incidental to mutant phenotype.
Earhomozygote#1N/Anormal00N/AN/A
Uterushomozygote#1N/Anormal00N/AN/A
Optic II nervehomozygote#1N/Anormal00N/AN/A
Epididymishomozygote#1N/AN/A0Not applicableN/AN/A
Nasal cavityhomozygote#1N/Anormal00N/AN/A
Toothhomozygote#1N/Anormal00N/AN/A
Femurhomozygote#1N/Anormal00N/AN/A
Kidneyhomozygote#1N/Anormal00N/AN/A
White adipose tissuehomozygote#1N/Anormal00N/AN/A
Testishomozygote#1N/AN/A0Not applicableN/AN/A
Rows per page: 

Histopathology images

Slc30a4em1(IMPC)TcpMouse #4kidney 
Slc30a4em1(IMPC)TcpMouse #2kidney 

Slc30a4em1(IMPC)TcpMouse #4lung 

Slc30a4em1(IMPC)TcpMouse #2pancreas 

Slc30a4em1(IMPC)TcpMouse #5salivary gland 
Slc30a4em1(IMPC)TcpMouse #4salivary gland 
Slc30a4em1(IMPC)TcpMouse #2salivary gland 
Slc30a4em1(IMPC)TcpMouse #3salivary gland 

Slc30a4em1(IMPC)TcpMouse #4liver 
Slc30a4em1(IMPC)TcpMouse #3liver 

The IMPC Newsletter

Get highlights of the most important data releases, news and events, delivered straight to your email inbox

Subscribe to newsletter